Uncategorized
VIDEO: Ocular Therapeutix president gives company update
MIAMI — At the CEDARS/ASPENS meeting, Amar Sawhney, president and CEO of Ocular Therapeutix, discusses the recent FDA acceptance of the new drug application for Dextenza.